A modelling study released in March gives a clue at which price the jab, lenacapavir, would be worth the health department’s ...

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 - but only if between two and ...

The biggest tail risk we are facing is a full-on trade war, which is why the market reacted so negatively to the so-called ...

A modelling study shows that lenacapavir could end Aids in South Africa by 2032 – but only if between two and four million ...

The Xpert MTB/Ultra molecular diagnostic test may become a viable option for detecting tuberculosis (TB) in the stool of ...